The client faces difficulties in accurately assessing drug stability outside labelled storage conditions due to manual processes, leading to delays, errors, drug wastage, increased costs, and potential risks to patient safety. The existing manual evaluation is time-consuming, prone to inaccuracies, and inadequate for timely decision-making during distribution and storage.
A mid-sized pharmaceutical manufacturer or distributor seeking to optimize drug storage, transportation, and compliance processes through real-time monitoring and automated stability assessments.
The implementation of this automated drug stability monitoring platform is expected to significantly reduce drug wastage, decrease manual workload, and improve regulatory compliance. By enabling near-instantaneous evaluation of stability excursions, the system can cut assessment times from weeks to minutes, leading to faster distribution decisions, enhanced product safety, longer shelf life, and substantial cost savings for pharmaceutical companies. These improvements collectively enhance supply chain efficiency, reduce risks to patient safety, and optimize resource utilization.